by GlobeNewsWire | Sep 13, 2016 | Globe Newswire
DEVON, Pa., Sept. 13, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the...
by GlobeNewsWire | Sep 13, 2016 | Globe Newswire
EL SEGUNDO, Calif., Sept. 13, 2016 (GLOBE NEWSWIRE) — A special committee consisting of the nominating and corporate governance committee of the board of directors (the “Committee”) of Griffin Capital Essential Asset REIT, Inc. (“GCEAR”) announced today that it...
by GlobeNewsWire | Sep 13, 2016 | Globe Newswire
MINNEAPOLIS, Sept. 13, 2016 (GLOBE NEWSWIRE) — GWG Holdings, Inc. (Nasdaq:GWGH), a specialty finance company in the life insurance secondary market, today announced it has closed the sale of its three- and five-year publicly registered L Bonds through the...
by GlobeNewsWire | Sep 13, 2016 | Globe Newswire
WALTHAM, Mass., Sept. 13, 2016 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases and disorders of the eye,...
by GlobeNewsWire | Sep 13, 2016 | Feature Box, Featured, FP, Globe Newswire
Reprocessing service for varicose vein ablation catheter continues to gain customers nearly five years after launch Excellent record of safety and reliability Reprocessing lowers costs and reduces medical waste for U.S. vein clinics MINNEAPOLIS, Sept. 13, 2016 (GLOBE...